JULIE PETERSON: Open Payments
NPI 1801357066 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,695 in 55 payments from 13 companies in 2025. Trend: 2023 $2,800 · 2024 $1,641 · 2025 $1,695
Food & beverage: $1,695
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $413 |
| Axsome Therapeutics, Inc. | 7 | $265 |
| ABBVIE INC. | 7 | $193 |
| Supernus Pharmaceuticals, Inc. | 6 | $184 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $138 |
| Vanda Pharmaceuticals Inc. | 5 | $136 |
| Neurocrine BioSciences, Inc. | 4 | $101 |
| Otsuka America Pharmaceutical, Inc. | 4 | $99 |
| Alkermes, Inc. | 3 | $68 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
Products named: COBENFY, Auvelity, VRAYLAR, Qelbree, CAPLYTA, REXULTI, INGREZZA, FANAPT.
Industry payments across FL — which companies pay providers there.
